Jiaxin Liu

ORCID: 0000-0002-8770-2093
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Inflammatory Biomarkers in Disease Prognosis
  • Advanced Drug Delivery Systems
  • Cancer Immunotherapy and Biomarkers
  • Electrospun Nanofibers in Biomedical Applications
  • Retinal Diseases and Treatments
  • Computational Drug Discovery Methods
  • RNA Interference and Gene Delivery
  • Inflammatory mediators and NSAID effects
  • Cytokine Signaling Pathways and Interactions
  • Image Enhancement Techniques
  • Corneal Surgery and Treatments
  • Osteoarthritis Treatment and Mechanisms
  • Cancer, Stress, Anesthesia, and Immune Response
  • Tryptophan and brain disorders
  • Polymer Surface Interaction Studies
  • Bioinformatics and Genomic Networks
  • SARS-CoV-2 and COVID-19 Research
  • Phagocytosis and Immune Regulation
  • Hydrogen Storage and Materials
  • HER2/EGFR in Cancer Research
  • Retinal and Macular Surgery
  • Ammonia Synthesis and Nitrogen Reduction
  • Cancer-related molecular mechanisms research
  • Gold and Silver Nanoparticles Synthesis and Applications

Meizhou City People's Hospital
2025

Jilin University
2015-2025

Chinese Academy of Medical Sciences & Peking Union Medical College
2014-2025

First Affiliated Hospital of Xi'an Jiaotong University
2019-2025

China Medical University
2024-2025

Third Hospital of Hebei Medical University
2022-2025

Hebei Medical University
2022-2025

Harbin Medical University
2021-2025

Chengdu Women's and Children's Central Hospital
2024

Chengdu Medical College
2024

Abstract Background Mutations in KRAS and BRAF genes are prevalent colorectal cancer (CRC), which strikingly promote tumorigenesis lead to poor response a variety of treatments including immunotherapy by activating the MAPK/ERK pathway. Thus, there is an urgent need discover effective therapeutic targets strategies. Methods CRISPR-Cas9 lentiviral knockout library was used screen suppressors anti-PD1 immunotherapy. Bioinformatic analysis analyze correlation between PHF8 expression immune...

10.1186/s13046-025-03338-2 article EN cc-by Journal of Experimental & Clinical Cancer Research 2025-02-25

Liposome, a widely used drug delivery system (DDS), still shows several disadvantages such as dominant clearance by liver and poor target organ deposition. To overcome the drawbacks of liposomes, we developed novel red blood cell (RBC)-liposome combined DDS to modulate tumor accumulation extend circulation life existing liposomal DDS. Here, RBCs, an ideal natural carrier DDS, were utilized carry liposomes avoid them undergo fast in blood. In this study, could either absorbed onto RBCs'...

10.1093/rb/rbad045 article EN cc-by Regenerative Biomaterials 2023-01-01

The PEGylated AuNPs have an adverse effect on the deformability and oxygen-delivering ability of erythrocytes through damage to cell membrane.

10.1039/c4nr01857e article EN Nanoscale 2014-01-01

Activated macrophages play a vital role in rheumatoid arthritis (RA) pathophysiology. CD44 is an overexpressed receptor on activated that potential target site for RA treatment. In this study, we prepared hyaluronic acid (HA) coated acid-sensitive polymeric nanoparticles (HAPNPs) composed of egg phosphatidylcholine, polyethylenimine, and poly (cyclohexane-1,4-diyl acetone dimethylene ketal) (PCADK) loaded with dexamethasone (Dex) the treatment RA. PCADK was used to form cores because its...

10.3390/molecules24010146 article EN cc-by Molecules 2019-01-02

Age-related macular degeneration is a multifactorial disease involving inflammation and choroidal neovascularization. Vascular endothelial growth factor (VEGF) has been regarded as potential therapeutic target to treat Dexamethasone can interfere with the expression or action of VEGF while bevacizumab targets combines VEGF. We propose electrostatically-conjugated bevacizumab-bearing dexamethasone-loaded poly (D,L-lactide-co-glycolide)/polyethylenimine nanoparticles (eBev-DPPNs) for...

10.2147/ijn.s217038 article EN cc-by-nc International Journal of Nanomedicine 2019-11-01

Docetaxel (DTX) is commonly used for breast cancer treatment. Tween 80 DTX dissolution in its clinical formulation causes severe hypersensitivity and other adverse reactions. In this study, trastuzumab (Tmab)-coated lipid-polymer hybrid nanoparticles (PLNs) were prepared, composed of poly (d, l-lactide- co-glycolide), PLGA; polyethylenimine (PEI); lipids. The PLGA/PEI/lipid formed a hydrophobic core, while Tmab was electrostatically adsorbed on the surface PLNs as ligand that targets human...

10.1177/1559325819872583 article EN cc-by-nc Dose-Response 2019-07-01

Bevacizumab, a vascular endothelial growth factor (VEGF)-targeting drug, is widely used as an off-label therapeutic for age-related macular degeneration (AMD). To reduce the monthly administration frequency, this study investigated microspheres comprising poly(d, l-lactide-co-glycolide)/poly(cyclohexane-1,4-diyl acetone dimethylene ketal) (PLGA/PCADK) blend that could be loaded with bevacizumab-dextran particles using solid-in-oil-in-water (S/O/W) emulsification. Control were also prepared...

10.1016/j.ijpharm.2019.04.012 article EN cc-by-nc-nd International Journal of Pharmaceutics 2019-04-05

Pulmonary fibrosis (PF) is a progressive interstitial disease characterized by extracellular matrix deposition and destruction of lung tissue structure. Emodin (Emo) natural active compound with anti-inflammatory antioxidant properties. It can prevent damage to alveolar epithelial cells reducing oxidative stress blocking the initiation PF, thereby caused ultimately achieving therapeutic purpose for PF. However, Emo featured low water solubility, rapid metabolic rate oral bioavailability,...

10.1080/1061186x.2025.2497369 article EN Journal of drug targeting 2025-04-23

Immune checkpoint blockade therapies fail to induce immune response in the vast majority of cancer patients, so developing robust adjuvants for increasing tumor is central effective immunotherapy. The Wnt/β-catenin pathway a crucial oncogenic signal relation evasion; however, none Wnt inhibitor under clinical or preclinical phases has demonstrated satisfactory specificity. Thus, new compounds modalities that specifically modulate will be great significance and value Herein, inspired by...

10.1021/acs.nanolett.9b03414 article EN Nano Letters 2019-11-20

Paclitaxel is widely used as a first-line chemotherapy agent to treat malignant tumors. However, paclitaxel causes peripheral nerve fiber damage and neuropathic pain in some patients. In addition, patients received are often accompanied by negative emotions such anxiety. The amygdala critically involved regulating signals, well purpose of this study clarify the role Ca2+/calmodulin-dependent protein kinase II (CaMKII)-positive glutamatergic neurons paclitaxel-induced affective symptoms....

10.3389/fpsyt.2022.869544 article EN cc-by Frontiers in Psychiatry 2022-04-14

Thyroid carcinoma (THCA) is the most common cancer of endocrine system. Natural killer (NK) cell play an important role in tumor immune surveillance. The aim this study was to explore possible molecular mechanisms involved NK THCA help management and treatment disease. All data were downloaded from public databases. Candidate hub genes associated with identified by limma, WGCNA singleR packages. Functional enrichment analysis performed on candidate genes. Hub Pearson correlation analysis....

10.1007/s12672-025-01779-x article EN cc-by-nc-nd Discover Oncology 2025-01-14

Abstract Background Paclitaxel (PTX) chemotherapy frequently induces cognitive impairment, which is closely associated with two key pathological processes: necroptosis of hippocampal neurons and microglial polarization. Necroptotic release damage-associated molecular patterns, triggering inflammatory responses. As the primary immune cells in central nervous system, microglia can exhibit either pro-inflammatory or anti-inflammatory activity depending on their polarization state. However,...

10.1515/med-2025-1182 article EN cc-by Open Medicine 2025-01-01

Since the survival of lymphoma patients who experience disease progression or relapse remains very poor, new therapeutic approaches and effective drugs are urgently needed. Here we show that auranofin (AF), an anti-rheumatoid drug thought to inhibit thioredoxin reductases (TXNRDs) as its mechanism action, exhibited potent activity against multiple cancer types, especially B cell lymphoma. Surprisingly, a knockdown TXNRD1 TXNRD2 did not cause significant cytotoxicity, suggesting abrogation...

10.1016/j.redox.2024.103245 article EN cc-by-nc Redox Biology 2024-06-18

Aim: To investigate diagnostic value of preoperative inflammatory biomarkers in pancreatic cancer (PCC). Materials & methods: Preoperative circulating Alb/Fib ratio, neutrophil/lymphocyte ratio (NLR), derived NLR (dNLR), platelet/lymphocyte and lymphocyte/monocyte were detected calculated 226 PCC individuals, 232 healthy controls 142 additional controls. Receiver-operating characteristic curve area under the (AUC) used to evaluate efficacy PCC. Results: Combined dNLR Alb could effectively...

10.2217/fon-2017-0339 article EN Future Oncology 2018-01-17

The gold nanoparticles (AuNPs) have been widely used as drug delivery systems at several biomedical fields. However, the effect of AuNPs on components human blood is not well characterized. firstly interacted with when using carries. Therefore, it urgent to investigate (including ligands AuNPs) blood, especially its components. In this study, we investigated possible effects polyethylene glycol-coated (PEG@AuNPs) and citric acid-coated (CT-AuNPs) cell function distribution those in including...

10.1080/21691401.2018.1468769 article EN Artificial Cells Nanomedicine and Biotechnology 2018-05-09
Coming Soon ...